Binje Vick

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 15

Top Venues

Leukemia

Blood

Nature communications

Nature biotechnology

Helmholtz Zentrum München

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Helmholtz Zentrum München

Germany

PostDoc :: Research Unit Apoptosis in Hematopoietic Stem Cells (AHS)

Johannes Gutenberg Universität Universitätsmedizin

Germany

PostDoc :: Medizinische Klinik und Poliklinik I

Publications

Adrian Gottschlich, Moritz Thomas, Ruth Grünmeier, Stefanie Lesch, Lisa Rohrbacher, Veronika Igl, Daria Briukhovetska, Mohamed-Reda Benmebarek, Binje Vick, Sertac Dede, Katharina Müller, Tao Xu, Dario Dhoqina, Florian Märkl, Sophie Robinson, Andrea Sendelhofert, Heiko Schulz, Öykü Umut, Vladyslav Kavaka, Christina Angeliki Tsiverioti, Emanuele Carlini, Sayantan Nandi, Thaddäus Strzalkowski, Theo Lorenzini, Sophia Stock, Philipp Jie Müller, Janina Dörr, Matthias Seifert, Bruno Loureiro Cadilha, Ruben Brabenec, Natalie Röder, Felicitas Rataj, Manuel Nüesch, Franziska Modemann, Jasmin Wellbrock, Walter Fiedler, Christian Kellner, Eduardo Beltrán, Tobias Herold, Dominik Paquet, Irmela Jeremias, Louisa von Baumgarten, Stefan Endres, Marion Subklewe, Carsten Marr, Sebastian Kobold
Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia. Nature biotechnology (2023)
Ehsan Bahrami, Jan Philipp Schmid, Vindi Jurinovic, Martin Becker, Anna-Katharina Wirth, Romina Ludwig, Sophie Kreissig, Tania Vanessa Duque Angel, Diana Amend, Katharina Hunt, Rupert Öllinger, Roland Rad, Joris Maximillian Frenz, Maria Solovey, Frank Ziemann, Matthias Mann, Binje Vick, Christian Wichmann, Tobias Herold, Ashok Kumar Jayavelu, Irmela Jeremias
Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo. Molecular cancer 22 (1) (2023)
Nora Philipp, Maryam Kazerani, Alyssa Nicholls, Binje Vick, Jan Wulf, Tobias Straub, Michaela Scheurer, Amelie Muth, Gerulf Hänel, Daniel Nixdorf, Monika Sponheimer, Malte Ohlmeyer, Sonja M Lacher, Bettina Brauchle, Anetta Marcinek, Lisa Rohrbacher, Alexandra Leutbecher, Kai Rejeski, Oliver Weigert, Michael von Bergwelt-Baildon, Sebastian Theurich, Roman Kischel, Irmela Jeremias, Veit L Bücklein, Marion Subklewe
T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals. Blood 140 (10) (2022)
Sebastian E Koschade, Kevin Klann, Shabnam Shaid, Binje Vick, Jan A Stratmann, Marlyn Thölken, Laura M Meyer, The Duy Nguyen, Julia Campe, Laura M Moser, Susanna Hock, Fatima Baker, Christian T Meyer, Frank Wempe, Hubert Serve, Evelyn Ullrich, Irmela Jeremias, Christian Münch, Christian H Brandts
Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia. Leukemia 36 (10) (2022)
Maike Roas, Binje Vick, Marc-André Kasper, Marina Able, Harald Polzer, Marcus Gerlach, Elisabeth Kremmer, Judith S Hecker, Saskia Schmitt, Andreas Stengl, Verena Waller, Natascha Hohmann, Moreno Festini, Alexander Edmund Ludwig, Lisa Rohrbacher, Tobias Herold, Marion Subklewe, Katharina S Götze, Christian P R Hackenberger, Dominik Schumacher, Jonas Helma-Smets, Irmela Jeremias, Heinrich Leonhardt, Karsten Spiekermann
TARGETING FLT3 BY NEW-GENERATION ANTIBODY-DRUG-CONJUGATE IN COMBINATION WITH KINASE INHIBITORS FOR TREATMENT OF AML. Blood (2022)
Christina Zeller, Daniel Richter, Vindi Jurinovic, Ilse A Valtierra-Gutiérrez, Ashok Kumar Jayavelu, Matthias Mann, Johannes W Bagnoli, Ines Hellmann, Tobias Herold, Wolfgang Enard, Binje Vick, Irmela Jeremias
Adverse stem cell clones within a single patient's tumor predict clinical outcome in AML patients. Journal of hematology & oncology 15 (1) (2022)
Eliza Yankova, Wesley Blackaby, Mark Albertella, Justyna Rak, Etienne De Braekeleer, Georgia Tsagkogeorga, Ewa S Pilka, Demetrios Aspris, Dan Leggate, Alan G Hendrick, Natalie A Webster, Byron Andrews, Richard Fosbeary, Patrick Guest, Nerea Irigoyen, Maria Eleftheriou, Malgorzata Gozdecka, Joao M L Dias, Andrew J Bannister, Binje Vick, Irmela Jeremias, George S Vassiliou, Oliver Rausch, Konstantinos Tzelepis, Tony Kouzarides
Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature 593 (7860) (2021)
Michela Carlet, Kerstin Völse, Jenny Vergalli, Martin Becker, Tobias Herold, Anja Arner, Daniela Senft, Vindi Jurinovic, Wen-Hsin Liu, Yuqiao Gao, Veronika Dill, Boris Fehse, Claudia D Baldus, Lorenz Bastian, Lennart Lenk, Denis Martin Schewe, Johannes W Bagnoli, Binje Vick, Jan Philipp Schmid, Alexander Wilhelm, Rolf Marschalek, Philipp J Jost, Christoph Cornelius Miething, Kristoffer Riecken, Marc Schmidt-Supprian, Vera Binder, Irmela Jeremias
In vivo inducible reverse genetics in patients' tumors to identify individual therapeutic targets. Nature communications 12 (1) (2021)
Enric Redondo Monte, Anja Wilding, Georg Leubolt, Paul Kerbs, Johannes W Bagnoli, Luise Hartmann, Wolfgang Hiddemann, Linping Chen-Wichmann, Stefan Krebs, Helmut Blum, Monica Cusan, Binje Vick, Irmela Jeremias, Wolfgang Enard, Sebastian Theurich, Christian Wichmann, Philipp A Greif
ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells. Oncogene 39 (15) (2020)
Sophie M Stief, Anna-Li Hanneforth, Sabrina Weser, Raphael Mattes, Michela Carlet, Wen-Hsin Liu, Michael D Bartoschek, Helena Domínguez Moreno, Matthias Oettle, Julia Kempf, Binje Vick, Bianka Ksienzyk, Belay Tizazu, Maja Rothenberg-Thurley, Hilmar Quentmeier, Wolfgang Hiddemann, Sebastian Vosberg, Philipp A Greif, Klaus H Metzeler, Gunnar Schotta, Sebastian Bultmann, Irmela Jeremias, Heinrich Leonhardt, Karsten Spiekermann
Loss of KDM6A confers drug resistance in acute myeloid leukemia. Leukemia 34 (1) (2019)
Jennifer R Lynch, Basit Salik, Patrick Connerty, Binje Vick, Halina Leung, Aster Pijning, Irmela Jeremias, Karsten Spiekermann, Toby Trahair, Tao Liu, Michelle Haber, Murray D Norris, Andrew J Woo, Philip J Hogg, Jianlong Wang, Jenny Y Wang
JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis. Leukemia 33 (6) (2019)
Michael Ruzicka, Lars M Koenig, Simone Formisano, Daniel F R Boehmer, Binje Vick, Eva-M Heuer, Hanna Meinl, Lorenz Kocheise, Marcus Zeitlhöfler, Julia Ahlfeld, Sebastian Kobold, Stefan Endres, Marion Subklewe, Peter Duewell, Max Schnurr, Irmela Jeremias, Felix S Lichtenegger, Simon Rothenfußer
RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade. Leukemia 34 (4) (2019)
Swati Garg, Armando Reyes-Palomares, Lixiazi He, Anne Bergeron, Vincent-Philippe Lavallée, Sébastien Lemieux, Patrick Gendron, Christian Rohde, Jianglong Xia, Prarabdha Jagdhane, Carsten Muller-Tidow, Daniel B Lipka, Suzan Imren, R Keith Humphries, Claudia Waskow, Binje Vick, Irmela Jeremias, Guillaume Richard Carpentier, Josée Hébert, Guy Sauvageau, Judith Barbara Zaugg, Frédéric Barabé, Caroline Pabst
Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML. Blood 134 (3) (2019)
Susan Klaeger, Stephanie Wilhelm, Mathias Wilhelm, Harald Polzer, Binje Vick, Paul-Albert Koenig, Maria Reinecke, Benjamin Ruprecht, Svenja Petzoldt, Chen Meng, Jana Zecha, Katrin Reiter, Huichao Qiao, Dominic Helm, Heiner Koch, Melanie Schoof, Giulia Canevari, Elena Casale, Stefania Re Depaolini, Annette Feuchtinger, Zhixiang Wu, Tobias K Schmidt, Lars Rueckert, Wilhelm Becker, Jan Huenges, Anne-Kathrin Garz, Bjoern-Oliver Gohlke, Daniel Paul Zolg, Gian Kayser, Tonu Vooder, Robert Preissner, Hannes Hahne, Neeme Tõnisson, Karl Kramer, Katharina Götze, Florian Bassermann, Judith Schlegl, Hans-Christian Ehrlich, Stephan Aiche, Axel Walch, Philipp A Greif, Sabine Schneider, Eduard Rudolf Felder, Juergen Ruland, Guillaume Médard, Irmela Jeremias, Karsten Spiekermann, Bernhard Kuster
The target landscape of clinical kinase drugs. Science (New York, N.Y.) 358 (6367) (2018)
Konstantinos Tzelepis, Etienne De Braekeleer, Demetrios Aspris, Isaia Barbieri, M S Vijayabaskar, Wen-Hsin Liu, Malgorzata Gozdecka, Emmanouil Metzakopian, Hamish D Toop, Monika Dudek, Samuel C Robson, Francisco Hermida-Prado, Yu Hsuen Yang, Roya Babaei-Jadidi, Dimitrios A Garyfallos, Hannes Ponstingl, Joao M L Dias, Paolo Gallipoli, Michael Seiler, Silvia Buonamici, Binje Vick, Andrew J Bannister, Roland Rad, Rabinder K Prinjha, John C Marioni, Brian James Patrick Huntly, Jennifer Batson, Jonathan C Morris, Cristina Pina, Allan Bradley, Irmela Jeremias, David O Bates, Kosuke Yusa, Tony Kouzarides, George S Vassiliou
SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4. Nature communications 9 (1) (2018)

Binje Vick.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Binje Vick